Document Detail


The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia.
MedLine Citation:
PMID:  19222478     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To clarify the relationship between the levels of JAK2 wild-type (WT) and V617F mutant-positive platelets in patients with essential thrombocythaemia (ET), we quantified mutant levels in purified cells from 10 V617F-positive patients prior to receiving cytoreductive therapy. Mutant levels were significantly higher in platelet than neutrophil RNA (P = 0.002), but the mutation was still only present in a sub-population of platelets (median 54%). When the absolute number of WT platelets was calculated, it was always within or above the normal platelet range, indicating that there is an aberration in the negative feedback to JAK2 WT platelets in ET.
Authors:
Jonathan R Lambert; Rosemary E Gale; David C Linch
Related Documents :
23645838 - Inhibition of hpa-1a alloantibody-mediated platelet destruction by a deglycosylated ant...
19958208 - Definition of reference ranges for the platelet distribution width (pdw): a local need.
6185158 - Busulphan: effect on platelet rna dependent dna polymerase--implications in the treatme...
19016918 - Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead t...
8808788 - Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone.
7756648 - A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial...
Publication Detail:
Type:  Journal Article     Date:  2009-01-12
Journal Detail:
Title:  British journal of haematology     Volume:  145     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-18     Completed Date:  2009-06-19     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  128-30     Citation Subset:  IM    
Affiliation:
Department of Haematology, University College London Cancer Institute, London, UK. jonathan.lambert@ucl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Platelets / enzymology
Humans
Janus Kinase 2 / genetics*
Mutation*
Neutrophils / enzymology
Platelet Count
RNA / genetics
Reverse Transcriptase Polymerase Chain Reaction
Thrombocythemia, Essential / blood*,  enzymology,  genetics
Chemical
Reg. No./Substance:
63231-63-0/RNA; EC 2.7.10.1/Janus Kinase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Guidelines for the diagnosis and management of disseminated intravascular coagulation.
Next Document:  The role of the Na+/Ca2+ exchanger, I and I in the genesis of dofetilide-induced torsades de pointes...